4//SEC Filing
MULROY DENNIS 4
Accession 0001276840-25-000003
CIK 0001370053other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:13 PM ET
Size
11.7 KB
Accession
0001276840-25-000003
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
MULROY DENNIS
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-12-16$20.16/sh+10,000$201,600→ 25,126 total - Sale
Common Stock
2025-12-16$44.62/sh−9,365$417,821→ 15,761 total - Sale
Common Stock
2025-12-16$45.21/sh−6,360$287,511→ 9,401 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-12-16−10,000→ 70,600 totalExercise: $20.16Exp: 2030-07-12→ Common Stock (10,000 underlying)
Footnotes (6)
- [F1]Reflects the acquisition of 1,324 shares acquired under the Company's ESPP.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 11, 2025.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.07 to $45.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.065 to $45.32 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The stock option is fully vested.
- [F6]In addition to the remaining options to purchase 70,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 339,440 shares of common stock, which options vest according to their terms.
Documents
Issuer
ANAPTYSBIO, INC
CIK 0001370053
Entity typeother
Related Parties
1- filerCIK 0001276840
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:13 PM ET
- Size
- 11.7 KB